$41.40
-0.0500 (-0.121%)
At Close: Jul 31, 2026
CellBxHealth rises on Qiagen tie-up to push Parsortix into more drug-development projects
06:20am, Tuesday, 18'th Nov 2025
Shares in CelLBxHealth PLC (AIM:CLBX, NSX:ANPCY, OTCQB:ANPCF) climbed 7% to 1.93p after the company unveiled a collaboration with Qiagen designed to bring its Parsortix circulating tumour cell platfor
CellBxHealth strikes co-marketing deal with Qiagen to widen use of Parsortix cancer platform
03:16am, Tuesday, 18'th Nov 2025
CelLBxHealth PLC (AIM:CLBX, NSX:ANPCY, OTCQB:ANPCF) has agreed a collaboration and co-marketing deal with Qiagen that will allow the diagnostics group to promote the UK company's Parsortix system to
Qiagen N.V. (QGEN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript
03:07pm, Monday, 17'th Nov 2025
Qiagen N.V. ( QGEN ) 7th Annual Wolfe Research Healthcare Conference November 17, 2025 12:40 PM EST Company Participants Thierry Bernard - CEO, MD & Member of Management Board Conference Call Particip
Qiagen (QGEN) International Revenue in Focus: Trends and Expectations
10:16am, Monday, 17'th Nov 2025
Evaluate Qiagen's (QGEN) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025
01:30am, Monday, 10'th Nov 2025
GERMANTOWN, Md. & VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the debut of QIAsymphony Connect, the next generation o
Why Qiagen (QGEN) is a Top Value Stock for the Long-Term
10:41am, Friday, 07'th Nov 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Seattle's Parse Biosciences to be acquired by Qiagen for $225M
01:49pm, Thursday, 06'th Nov 2025
Seattle's Parse Biosciences is teed up for an acquisition by Qiagen, a Netherlands-based holding company, in a $225 million cash
Qiagen N.V. (QGEN) Q3 2025 Earnings Call Transcript
03:51pm, Wednesday, 05'th Nov 2025
Qiagen N.V. ( QGEN ) Q3 2025 Earnings Call November 5, 2025 9:30 AM EST Company Participants John Gilardi - VP & Head of Corporate Communications Thierry Bernard - CEO, MD & Member of Management Board
Qiagen N.V. (NYSE:QGEN) Receives Consensus Recommendation of “Hold” from Analysts
03:48am, Wednesday, 05'th Nov 2025
Qiagen N.V. (NYSE: QGEN - Get Free Report) has been given a consensus rating of "Hold" by the ten analysts that are presently covering the stock, Marketbeat Ratings reports. Seven analysts have rated
Here's What Key Metrics Tell Us About Qiagen (QGEN) Q3 Earnings
05:30pm, Tuesday, 04'th Nov 2025
Although the revenue and EPS for Qiagen (QGEN) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Stre
Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates
05:16pm, Tuesday, 04'th Nov 2025
Qiagen (QGEN) came out with quarterly earnings of $0.61 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.59 per share a year ago.
QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase
01:04pm, Tuesday, 04'th Nov 2025
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results for the third quarter of 2025 and reaffirmed its outlook for soli
QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions
01:03pm, Tuesday, 04'th Nov 2025
VENLO, Netherlands & SEATTLE--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has entered into a definitive agreement to fully acquire Parse Bi
QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing
05:05pm, Tuesday, 28'th Oct 2025
VENLO, Netherlands, & GERMANTOWN, Maryland--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the 4,000th placement of its QIAcube Connect instrumen
Analysts Estimate Qiagen (QGEN) to Report a Decline in Earnings: What to Look Out for
11:08am, Tuesday, 28'th Oct 2025
Qiagen (QGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sign In
Buy QGEN